Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rejuvaskin is a private U.S. skin health company focused on physician-recommended and direct-to-consumer products for scar management, radiation-related skin care, sensitive skin, sun care, and healthy aging. The company markets medical-grade silicone scar products such as RejûvaSil and Scar Fx, along with Skin Recovery Cream for radiation dermatitis support and other topical skin health products. Rejuvaskin positions itself as a science-backed skin health brand serving both medical professionals and patients, with products sold globally. It appears to operate primarily as a commercial skincare and medical-device-adjacent company rather than a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rejuvaskin.